Correlation Between CSL and WUXI BIOLOGICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CSL and WUXI BIOLOGICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and WUXI BIOLOGICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL LTD SPONADR and WUXI BIOLOGICS UNSPADR2, you can compare the effects of market volatilities on CSL and WUXI BIOLOGICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of WUXI BIOLOGICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and WUXI BIOLOGICS.

Diversification Opportunities for CSL and WUXI BIOLOGICS

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between CSL and WUXI is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding CSL LTD SPONADR and WUXI BIOLOGICS UNSPADR2 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WUXI BIOLOGICS UNSPADR2 and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL LTD SPONADR are associated (or correlated) with WUXI BIOLOGICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WUXI BIOLOGICS UNSPADR2 has no effect on the direction of CSL i.e., CSL and WUXI BIOLOGICS go up and down completely randomly.

Pair Corralation between CSL and WUXI BIOLOGICS

Assuming the 90 days trading horizon CSL LTD SPONADR is expected to under-perform the WUXI BIOLOGICS. But the stock apears to be less risky and, when comparing its historical volatility, CSL LTD SPONADR is 3.1 times less risky than WUXI BIOLOGICS. The stock trades about -0.11 of its potential returns per unit of risk. The WUXI BIOLOGICS UNSPADR2 is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  338.00  in WUXI BIOLOGICS UNSPADR2 on September 23, 2024 and sell it today you would earn a total of  80.00  from holding WUXI BIOLOGICS UNSPADR2 or generate 23.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CSL LTD SPONADR  vs.  WUXI BIOLOGICS UNSPADR2

 Performance 
       Timeline  
CSL LTD SPONADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CSL LTD SPONADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking indicators, CSL is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
WUXI BIOLOGICS UNSPADR2 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in WUXI BIOLOGICS UNSPADR2 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, WUXI BIOLOGICS reported solid returns over the last few months and may actually be approaching a breakup point.

CSL and WUXI BIOLOGICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CSL and WUXI BIOLOGICS

The main advantage of trading using opposite CSL and WUXI BIOLOGICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, WUXI BIOLOGICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WUXI BIOLOGICS will offset losses from the drop in WUXI BIOLOGICS's long position.
The idea behind CSL LTD SPONADR and WUXI BIOLOGICS UNSPADR2 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume